Event Brief
Mar 23, 2026 at 1:06 PM ET
Gilead nears $2bn deal for autoimmune biotech Ouro Medicines
By The BriefBrief
Gilead Sciences plans to acquire Ouro Medicines for up to $2 billion, leveraging its rising share price.
WHO: Gilead Sciences
WHAT: acquisition of Ouro Medicines
WHEN: Mar 23, 2026 at 12:33 PM ET
WHERE: California
WHY: to take advantage of surging share price for takeovers
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21432 of 21432
Same format. Every time.
Continue reading — sign in or create a free account with
